PlexBio Co., Ltd. (TPEX:6572)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
6.89
-0.04 (-0.58%)
Mar 10, 2026, 12:59 PM CST
-39.56%
Market Cap 718.29M
Revenue (ttm) 153.06M
Net Income (ttm) -64.51M
Shares Out 103.65M
EPS (ttm) -0.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 300
Average Volume 117,259
Open 7.00
Previous Close 6.93
Day's Range 6.60 - 7.57
52-Week Range 6.65 - 12.70
Beta 0.18
RSI 32.19
Earnings Date Apr 27, 2026

About PlexBio

PlexBio Co., Ltd. develops and manufactures in vitro diagnostic reagents for molecular biology and immunology projects. It offers workflow navigation services; automated sample preparation kits; IntelliPlex platform that is designed for πCode technology with throughput sample-to-answer multiplexing assays; oncology assays, a portfolio for advanced molecular testing; and πCode coupling buffer sets. PlexBio Co., Ltd. was founded in 2009 and is based in Taipei, Taiwan. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2009
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6572
Full Company Profile

Financial Performance

In 2024, PlexBio's revenue was 128.06 million, a decrease of -23.40% compared to the previous year's 167.18 million. Losses were -61.63 million, 5.30% more than in 2023.

Financial Statements

News

There is no news available yet.